Abstract:Ethnopharmacological relevance Yupingfeng San (YPFS) is a classic rousing prescription in Chinese medicine, with widly clinical application and remarkably curative effect. It consists of three herbs named Astragalus mongholicus Bunge (Huangqi), Atractylodes rubra Dekker (Baizhu) and Saposhnikovia divaricata (Turcz.) Schischk. (Fangfeng), and has a variety of pharmacological activities including immune regulation, antioxidant, anti-tumor, regulation of cytokines, etc. Aim of the study It has been proved that YPFS exerts its anti-tumor effect through enhancing the systemic and local immune responses in tumor patients, moreover, it has the direct tumor-suppressing effect and can reduce the adverse reactions caused by radiotherapy and chemotherapy drugs. Therefore, in this study, we explored the potential anti-HCC mechanism of YPFS based on HTS 2 technology and system pharmacology, aiming to provide a scientific basis for the clinical application of YPFS and a new strategy for Chinese medicine research. Materials and methods In this study, systems pharmacology plus high throughput sequencing-based high throughput screening(HTS 2 ) technology, and experimental validation were used to investigate the therapeutic mechanisms and the chemical basis of YPFS in HCC treatment. Firstly, the potential therapeutic targets and signaling pathways of YPFS in the treatment of HCC were obtained through systems pharmacology. Subsequently, HTS 2 technology combined with PPI network analysis were used to reveal potential therapeutic targets. Finally, the anti-HCC effects and underlying mechanisms of YPFS were further verified in vitro in human hepatocellular carcinoma cell lines. Moreover, the possible chemical basis was explored by drug target verification and molecular docking technology. Results In total, 183 active ingredients were predicted by YPFS screening and 49 anti-HCC targets were further identified. Most of these targets were enriched into the "MAPK pathway", and the expression of 37 genes was significantly changed after herb treatment. Among them, 5 key targets, including VEGFA, GRB2, JUN, PDGFRB and CDC42, were predicted by protein-protein interaction (PPI) network analysis. According to our results, YPFS inhibited the proliferation, induced the apoptosis and caused cell cycle arrest of HCC cells. In addition, YPFS significantly reduced P38 gene expression. Fangfeng, one of the three herbs in YPFS, significantly down-regulated the expression of more target genes than that of the other two herbs. Lastly, as revealed by molecular docking analysis, 4′-O-glucosyl-5-O-methylvisamminol, an active ingredient identified in Fangfeng, showed a high affinity for P38 . Conclusion Taken together, this study shows that YPFS possesses the activities of anti-proliferation and pro-apoptosis in treating HCC, which are achieved by inhibiting the MAPK signaling pathway. P38 is one of the critical targets of YPFS in treating HCC, which may be directly bound and inhibited by 4′-O-glucosyl-5-O-methylvisamminol, a compound derived from YPFS.

Study on the mechanism of Yupingfeng powder in the treatment of immunosuppression based on UPLC.QTOF.MS, network pharmacology and molecular biology verification

A systematic pharmacology-based in vivo study to reveal the effective mechanism of Yupingfeng in asthma treatment

Yupingfeng Powder relieves the immune suppression induced by dexamethasone in mice

Exploring the action mechanism and effective components of Yupingfeng powder on influenza based on computational system pharmacology and metabolomics

The immunomodulatory effects of Yupingfengsan and oral liquid Fuqizhihan granule act on immunosuppressive mice

Identifying absorbable bioactive constituents of Yupingfeng Powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis

Network Pharmacology and Molecular Docking Study of Yupingfeng Powder in the Treatment of Allergic Diseases

Immuno-enhancement effects of Yifei Tongluo Granules on cyclophosphamide-induced immunosuppression in Balb/c mice

Analysis of Immunostimulatory Activity of Polysaccharide Extracted from Yu-Ping-Feng in Vitro and in Vivo

Pharmacokinetic–pharmacodynamic evaluation of the major component astragaloside IV on the immunomodulatory effects of Yu-ping-feng prescription

Effects of Yupingfeng San containing Radix Hedysari or Radix Astragali on the splenic lymphocyte activation in SAMP8 mice

Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS 2 technology

The regulatory effects of Pseudostellaria heterophylla polysaccharide on immune function and gut flora in immunosuppressed mice

Network Pharmacology Combined with an Experimental Validation Study to Reveal the Effect and Mechanism of Eucommia ulmoides Leaf Polysaccharide against Immunomodulation

YuPingFengSan ameliorates LPS-induced acute lung injury and gut barrier dysfunction in mice

A Serum Pharmacological Study on the Immunoregulatory Effects of Yu Ping Feng Pulvis in Mice

Influence of Yupingfeng Powder containing Radix Hedysari or Radix Astragali on splenic T lymphocyte and PI3K expression in SAMP8 mice

Study on Compound YuPingFengSan Oral Liquid Improving Cellular Immunity of Mice

Immune-enhancing activity of polysaccharides and flavonoids derived from Phellinus igniarius YASH1

Mechanisms and molecular targets of the Yu-Ping-Feng powder for allergic rhinitis, based on network pharmacology

Studies of compound Chinese medicine on immunosuppression mice promoting immune function